Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the ...

If recent headlines are any indication, 2025 will be a pivotal year for setting the course of private equity investment in ...

Since it was established in 2005, the Georgia Gwinnett College (GGC) campus has seen accelerated growth, expanding to a ...

Mothers with multiple sclerosis had an elevated incidence and prevalence of peripartum mental illness vs. mothers without MS ...

The Preeclampsia Foundation announced today the recipients of its 2025 Peter Joseph Pappas Research Grants. Based on the recommendations of its Scientific Advisory Council, the Preeclampsia Foundation ...

The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid painkiller for treating moderate to severe pain in what the FDA considered the ...

Graduate Aptitude Test in Engineering (GATE) 2025 exam begins tomorrow, February 1 - 16, 2025. Held by Indian Institute of ...

Tectonic Therapeutic (TECX) stock surges on positive interim data from Phase 1b trial for lead candidate TX45 in patients ...

SaponiQx, a leader in next-generation saponin-based adjuvant discovery and a subsidiary of Agenus Inc., today announced the publication of their latest preclinical data in the journal Vaccines. The ...

COLTYN JACOBS ...

Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...

HealthDay News — Mothers with multiple sclerosis (MS) have an elevated incidence and prevalence of peripartum mental illness, according to a study published online Jan. 22 in Neurology.